These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9135508)

  • 1. Combination of oral idarubicin and prednimustine in advanced breast cancer: a phase II study.
    Barnadas A; Mendiola C; Casado A; Villar A; Jimeno J; Clerigue M; Rosell R; Diaz-Rubio E; Cortés-Funes H; García de Paredes M
    Eur J Cancer; 1997 Feb; 33(2):312-5. PubMed ID: 9135508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II study of an oral combination of doxifluridine, prednimustine and idarubicin (FUPRIDA) for first line treatment of advanced breast cancer.
    Alberto P
    Ann Oncol; 1993 May; 4(5):423-5. PubMed ID: 8353076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of patients with high-grade non-Hodgkin's lymphoma aged over 70 years with an all-oral regimen combining idarubicin, etoposide and alkylators.
    Morra E; Gargantini L; Nosari A; Barbarano L; Pungolino E; Santoleri L; Bernuzzi P
    Crit Rev Oncol Hematol; 2000 Aug; 35(2):95-100. PubMed ID: 10936466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitozantrone and prednimustine in the treatment of advanced breast cancer--a toxic regimen with low activity.
    O'Brien ME; Eccles DM; Allen SG; Knight G; Rodger A; Chetty U; Smyth JF; Leonard RC
    Cancer Chemother Pharmacol; 1991; 28(5):402-4. PubMed ID: 1914086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I - II study of oral idarubicin, tegafur and levo-folinate in patients with pretreated advanced breast cancer.
    Cilenti G; Tozzi L; Suriano A; Tartarone A; Lelli G
    J Chemother; 1999 Oct; 11(5):402-6. PubMed ID: 10632388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prednimustine combined with mitoxantrone and 5-fluorouracil for first and second-line chemotherapy in advanced breast cancer.
    Samonigg H; Stöger H; Kasparek AK; Schmid M; Dusleag J; Pfeiffer K; Smola M; Steindorfer P; Lechner P
    Cancer Chemother Pharmacol; 1991; 27(6):477-80. PubMed ID: 2013118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase III trial comparing prednimustine (LEO 1031) to chlorambucil plus prednisolone in advanced breast cancer.
    Løber J; Mouridsen HT; Christiansen IE; Dombernowsky P; Mattsson W; Rørth M
    Cancer; 1983 Nov; 52(9):1570-6. PubMed ID: 6352005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total body irradiation and prednimustine in chronic lymphocytic leukemia and low grade non-Hodgkin's lymphomas. A 9-year experience at a single institution.
    Roncadin M; Arcicasa M; Zagonel V; Bortolus R; Valeri P; Pinto A; De Paoli A; Franchin G; Carbone A; Trovò MG
    Cancer; 1994 Aug; 74(3):978-84. PubMed ID: 8039128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of idarubicin and cyclophosphamide administered orally in untreated postmenopausal breast cancer patients. A phase II study.
    Kolarić K; Mechl Z
    Oncology; 1991; 48(2):93-6. PubMed ID: 1997944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral chemotherapy with idarubicin plus cyclophosphamide in advanced breast cancer.
    Pronzato P; Bertelli G; Amoroso D; Pennucci C; Gardin G; Guido T; Rosso P
    Chemotherapy; 1991; 37(6):449-53. PubMed ID: 1760945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary analysis of combined treatment with prednimustine and 4'epidoxorubicin in advanced breast cancer.
    Aapro MS; Forni M; Krauer F; Alberto P; Wählby S
    Semin Oncol; 1986 Mar; 13(1 Suppl 1):35-8. PubMed ID: 3456646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination chemotherapy with prednimustine, adriamycin, vincristine (VAP) in advanced breast cancer. A phase II study.
    Kosmidis PA; Fountzilas G; Athanassiou A; Karabelis A; Mylonakis N; Tsavaris N; Karvounis N; Bacojiannis C
    Chemioterapia; 1987 Dec; 6(6):393-5. PubMed ID: 3435921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idarubicin and cyclophosphamide--an active oral chemotherapy regimen for advanced breast cancer.
    Leonard RC; Cameron DA; Anderson A; Ostrowski J; Howell A
    Crit Rev Oncol Hematol; 2000 Jan; 33(1):61-6. PubMed ID: 10714963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prednimustine, methotrexate, 5-fluorouracil, mitoxantrone and tamoxifen for advanced breast cancer in postmenopausal women. A phase II trial.
    Andersson M; Mouridsen HT
    Acta Oncol; 1988; 27(3):235-9. PubMed ID: 3415852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitoxantrone and prednimustine combination chemotherapy in breast cancer.
    Kaufmann M; Schmid H; Raeth U
    J Chemother; 1989 Jul; 1(4 Suppl):1191-3. PubMed ID: 16312829
    [No Abstract]   [Full Text] [Related]  

  • 16. Phase II study of oral idarubicin in elderly patients with advanced breast cancer.
    Chevallier B; Monnier A; Metz R; Namer M; Marty M; Roche H; Bastit P; Hurteloup P
    Am J Clin Oncol; 1990 Oct; 13(5):436-9. PubMed ID: 2220664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination chemotherapy with oral idarubicin and cyclophosphamide for metastatic breast cancer.
    Lopez M; Vici P; Carpano S; Natali M; Ganzina F; Conti EM; Di Lauro L
    J Cancer Res Clin Oncol; 1991; 117(1):61-4. PubMed ID: 1997473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined cytotoxic and endocrine treatment of postmenopausal patients with advanced breast cancer: preliminary results of a phase II study of the combination of prednimustine, novantrone, methotrexate, 5-fluorouracil, and tamoxifen.
    Mouridsen HT; Andersson M; Pedersen L
    Semin Oncol; 1986 Mar; 13(1 Suppl 1):39-41. PubMed ID: 3952520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prednimustine in combination with methotrexate and 5-fluorouracil in advanced breast cancer: a phase I-II study.
    Mouridsen HT; Boesen E
    Breast Cancer Res Treat; 1983; 3(1):85-9. PubMed ID: 6871484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral idarubicin in the treatment of advanced breast cancer.
    Bastholt L; Dalmark M; Jakobsen A; Gadeberg CC; Sandberg E; Mouridsen HT
    Acta Oncol; 1989; 28(6):893-7. PubMed ID: 2611039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.